Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
Phuong H. D. Nguyen, Martin Wasser, Chong Teik Tan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 99
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 78
Single cell deciphering of progression trajectories of the tumor ecosystem in head and neck cancer
Zhanli Liu, Xiangyan Meng, Rujuan Bao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Hyung‐Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 699-707
Open Access | Times Cited: 24
Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 18
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway
Yunzhi Liu, Qishan Xu, Fan Deng, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 39
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 33
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 25
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma
Maria Effenberger, Silvio Waschina, Christina Bronowski, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 23
Immunotherapy for hepatocellular carcinoma
Alexa Childs, Gloryanne Aidoo-Micah, Mala K. Maini, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101130-101130
Closed Access | Times Cited: 13
Translational research on drug development and biomarker discovery for hepatocellular carcinoma
Valerie Chew, Chien-Huai Chuang, Chiun Hsu
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 10
Harnessing Immunotherapy for Hepatocellular Carcinoma: Principles and Emerging Promises
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access | Times Cited: 1
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 22
Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 20
The role of liver cancer stem cells in hepatocellular carcinoma metastasis
Qinghui Niu, Susu Ye, Zhao Liu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma
Stefania De Lorenzo, Francesco Tovoli, Franco Trevisani
Cancers (2022) Vol. 14, Iss. 19, pp. 4616-4616
Open Access | Times Cited: 28
Vascular endothelial growth factor A is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma
Yuchen Qi, Yinghui Song, Meng‐Ting Cai, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 4, pp. 538-552
Open Access | Times Cited: 12
Galectin‐1‐Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs
Xizhi Yu, Junjie Qian, Limin Ding, et al.
Advanced Science (2025)
Open Access
Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma
Tianxing Zhou, Quan Man, Xueyang Li, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 3, pp. 196-217
Open Access | Times Cited: 8
Immune Response and Metastasis—Links between the Metastasis Driver MACC1 and Cancer Immune Escape Strategies
Sebastian Torke, Wolfgang Walther, Ulrike Stein
Cancers (2024) Vol. 16, Iss. 7, pp. 1330-1330
Open Access | Times Cited: 3
Clinical significance of the Naples prognostic score in predicting short‐ and long‐term postoperative outcomes of patients with hepatocellular carcinoma
Kiyotaka Hosoda, Akira Shimizu, Kôji Kubota, et al.
World Journal of Surgery (2024)
Closed Access | Times Cited: 3
Uncovering the mechanism of cancer-associated fibroblasts induced immune evasion of hepatocellular carcinoma cells via in situ fluorescence imaging
Chuanchen Wu, Yuantao Mao, Fanghui Zhang, et al.
Sensors and Actuators B Chemical (2023) Vol. 389, pp. 133891-133891
Closed Access | Times Cited: 7
LOXL4 Shuttled by Tumor Cells–derived Extracellular Vesicles Promotes Immune Escape in Hepatocellular Carcinoma by Activating the STAT1/PD-L1 Axis
Zhao Le, Ruifeng Pei, Yiren Ding, et al.
Journal of Immunotherapy (2023) Vol. 47, Iss. 2, pp. 64-76
Closed Access | Times Cited: 7
CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
Kaihua Tang, Xiaoting Li, Jianwen Mo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top